TP53 and mantle cell lymphoma: CDC20 inhibitor apcin and p53 agonist nutlin-3a were used to confirm the effect of inhibiting CDC20 or activating p53 on cell proliferation, apoptosis, cell cycle, migration and invasion abilities of MCL cells.